Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $1.42 in the prior trading day, Standard BioTools Inc (NASDAQ: LAB) closed at $1.38, down -2.82%. In other words, the price has decreased by -$2.82 from its previous closing price. On the day, 1.96 million shares were traded. LAB stock price reached its highest trading level at $1.4601 during the session, while it also had its lowest trading level at $1.35.
Ratios:
Our goal is to gain a better understanding of LAB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.41 and its Current Ratio is at 3.76. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on April 16, 2024, initiated with a Buy rating and assigned the stock a target price of $3.50.
On April 04, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $3.25.
On July 12, 2023, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $4.KeyBanc Capital Markets initiated its Overweight rating on July 12, 2023, with a $4 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 12 ’24 when Black Jeffrey G. bought 57,971 shares for $2.12 per share.
Taich Adam bought 45,851 shares of LAB for $91,725 on Sep 09 ’24. On Aug 27 ’24, another insider, Casdin Partners Master Fund, L, who serves as the Director of the company, bought 250,000 shares for $2.19 each. As a result, the insider paid 546,750 and bolstered with 54,025,821 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LAB now has a Market Capitalization of 513717440 and an Enterprise Value of 188976768. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.30 while its Price-to-Book (P/B) ratio in mrq is 1.05. Its current Enterprise Value per Revenue stands at 1.212 whereas that against EBITDA is -1.653.
Stock Price History:
The Beta on a monthly basis for LAB is 1.57, which has changed by -0.42259413 over the last 52 weeks, in comparison to a change of 0.19995654 over the same period for the S&P500. Over the past 52 weeks, LAB has reached a high of $3.04, while it has fallen to a 52-week low of $1.21. The 50-Day Moving Average of the stock is -22.87%, while the 200-Day Moving Average is calculated to be -30.55%.
Shares Statistics:
The stock has traded on average 1.78M shares per day over the past 3-months and 1928620 shares per day over the last 10 days, according to various share statistics. A total of 372.26M shares are outstanding, with a floating share count of 360.48M. Insiders hold about 3.16% of the company’s shares, while institutions hold 73.48% stake in the company. Shares short for LAB as of 1736899200 were 13324142 with a Short Ratio of 7.51, compared to 1734048000 on 13310534. Therefore, it implies a Short% of Shares Outstanding of 13324142 and a Short% of Float of 7.35.
